Bahrain grants emergency use approval for a vaccine candidate produced in a partnership between Sinopharm and Abu Dhabi-based artificial intelligence and cloud computing company Group 42 on frontline workers.
Bahrain announces to grant emergency use approval for a vaccine candidate that produced in a partnership between Sinopharm’s China National Biotec Group (CNBG) and Abu Dhabi-based artificial intelligence and cloud computing company Group 42 (G42) on frontline workers.
Bahrain grants emergency use approval for a vaccine candidate produced in a partnership between Sinopharm's China National Biotec Group (CNBG) and Abu Dhabi-based artificial intelligence and cloud computing company Group 42 (G42) on frontline workers.
Bahrain grants emergency use approval for a vaccine candidate produced in a partnership between Sinopharm and Abu Dhabi-based artificial intelligence and cloud computing company Group 42 on frontline workers.